ClinicalTrials.gg
RecruitingNCT06456229PICCS-1Updated Jun 13, 2024

Time to Return of Bowel Function Following Perioperative Probiotics in Colorectal Cancer Surgery

An interventional study of Nestle Isocal and Nestle Boost Optimum in Colorectal Cancer, Ileus Postoperative and Flatus, sponsored by National University Hospital, Singapore. Recruiting at 1 site in Singapore. Open to participants aged 21 Years to 99 Years. Per ClinicalTrials.gov, last updated 2024-06-13.

Sponsored by National University Hospital, Singapore · Not applicable, Interventional, and Treatment

How we know

From the registry’s dates

  • Primary completion was expected by May 2025, 1 year 6 months ago, but the record still lists the study as recruiting.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
162
Allocation
Randomized
Ages
21 Years to 99 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 63 studies in Colorectal Neoplasms with a site in Singapore — 13 open to participants now, 20 under way, 5 of them phase 3. Colorectal Neoplasms · Singapore.

Planned enrollment
30th of 54
162 · median 180
Started
2024
with 1 other
No phase
9 of 63
2 open now
Primary completion
2025-05
later than 4 of 19 live
Registered
57th of 63
by date
Lead sponsor
9 of 63
National University Hospital, Singapore

Among the 63 studies in Colorectal Neoplasms with a site in Singapore, this one is the 30th largest by planned enrollment of the 54 interventional ones that give a count, is one of 2 that started in 2024, is one of 9 with no phase, reaches primary completion later than 4 of the 19 other live ones, and was the 57th registered.

Colorectal Neoplasms

6,556 studies on the registry are indexed under Colorectal Neoplasms; 1,664 are open to participants now.

Browse Colorectal Neoplasms studies →

Open to participants now

13 of the 63 studies in Colorectal Neoplasms with a site in Singapore are open now. Recruiting first, the newest first:

7 more — sign in →

All 13 open studies →

A study can be open while its sites in Singapore have not opened yet or have stopped. Only those recruiting at a site in Singapore →

Who these studies take

Of the 1,179 Colorectal Neoplasms studies recruiting now, 762 (65%) set no upper age limit and 264 (22%) stop at 75 or younger; 48 take children under 18; 123 take healthy volunteers.

This study: 21 Years to 99 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 63 studies in Colorectal Neoplasms with a site in Singapore, or all of them as a file.
02

Study summary

There is pre-existing evidence that probiotics could be useful in the improvement of ileus rates. One metaanalysis of 30 studies demonstrated a reduction in the prevalence of post-operative ileus as determined by time to flatus, time to defecation, as well as postoperative abdominal distension (PMID:37373843). More broadly in gastrointestinal surgery, a meta-analysis of 21 randomised controlled trials similarly affirmed the speedier recovery of gastrointestinal function after surgery when probiotics were administered (PMID: 35231076). In spite of these advantages, the routine use of probiotics perioperatively for colorectal cancer surgery is not performed in Singapore. We therefore seek to perform a trial to investigate whether probiotic administration perioperatively may reduce post operative ileus rates.

03

Conditions studied

  • Colorectal Cancer
  • Ileus Postoperative
  • Flatus
  • Diet, Healthy

Keywords

  • colorectal cancer
  • colorectal surgery
  • nutritional supplementation
  • probiotics
  • time to bowel movement
  • time to flatus
  • length of stay
  • complications
04

Who can participate

Ages eligible
21 Years to 99 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  1. undergoing elective colorectal cancer surgery in which an oncologic resection is planned
  2. age between 21 and 99 years at the time of consent
  3. willing to consider oral nutritional supplementation
  4. on an early recovery after surgery (ERAS) pathway
  5. able to provide

Exclusion criteria

Exclusion Criteria:

  1. patients with known to probiotic use
  2. patients undergoing emergency surgery
  3. taking any other form of probiotics
  4. taking oral antibiotics within 7 days of commencement of study
  5. vulnerable patients including pregnant patients, inmates, and those who are cognitively impaired and therefore are not able to provide .
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

Contraindication

A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Quadruple (Participant, Care provider, Investigator, Outcomes assessor)
Enrollment
162 participants (estimated)

Study arms

  • No intervention
    Arm 1

    Control arm with no nutritional supplementation

  • Active comparator
    Arm 2

    Control arm with nutritional supplementation but without probiotics

    Dietary Supplement: Nestle Isocal

  • Experimental
    Arm 3

    Nutritional supplementation with probiotics

    Dietary Supplement: Nestle Boost Optimum

Interventions

  • Dietary supplementNestle Isocal

    Nestle Isocal

  • Dietary supplementNestle Boost Optimum

    Nestle Boost Optimum

06

What researchers measure

Primary outcomes

  1. Time to bowel movement

    This records the number of days from the day of surgery before the first bowel movement was experienced by the patient.

    Time frame: 0 - 14 days

Secondary outcomes

  1. Time to flatus

    This records the number of days from the day of surgery before the first flatus was experienced by the patient.

    Time frame: 0 - 14 days

  2. Adverse events

    Any adverse events related to the intervention. This comprises predominantly gastrointestinal related complications

    Time frame: From commencement of the intervention to 30 days after surgery

  3. Infective complications

    Any infective complications which may occur in the postoperative period.

    Time frame: From date of surgery to 30 days after surgery

  4. Length of hospital stay

    This records the number of days following surgery before the patient is discharged.

    Time frame: 0 - 14 days

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: No — Individual participant data will not be shared.

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Jul 2024; primary completion for May 2025, 10 months later.

Of 900 non-industry interventional studies with no phase under Colorectal Neoplasms, half reached primary completion within 32 months of starting (the median), counting those still running; a quarter within 15 and three quarters within 61. This study's planned 10 months is below that.

Counting every sponsor, half of 958 studies reached it within 31 months; a quarter within 14 and three quarters within 60.

How these figures are worked out, and which studies are left out of them.

Registered
Jun 6, 2024
First posted
Jun 13, 2024
StartEst.
Jul 1, 2024
Primary completionEst.
May 1, 2025
CompletionEst.
May 1, 2025
Last update
Jun 13, 2024
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jun 13, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06456229
Responsible party
Sponsor
First posted
Jun 13, 2024
Start date
Jul 1, 2024 (estimated)
Primary completion
May 1, 2025 (estimated)
Completion
May 1, 2025 (estimated)
Last update
Jun 13, 2024

Study contacts

Dedrick Chan, MBBS, DPhil
Contact
surckhd@nus.edu.sg
67795555

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion